# No health without mental health

[Watch the video](https://webtv.lundbeck.com/secret/71338087/4348133e63758040e5b4bd7faf040d96)

# Advancing brain health. Transforming lives.

[Learn more about Lundbeck as a workplace](https://webtv.lundbeck.com/v.ihtml/player.html?token=313aa055075929cfd5f76784eb741741&source=embed&photo_id=103775234)

# Advancing brain health. Transforming lives.

### 20 years on painkillers

Gao Lei, aged 42, lives in Beijing in China. She graduated in medicine and works as a brand manager at a company where she is responsible for organizing and hosting conferences. She is a mother and a migraine patient for more than 20 years.

[Read more](/content/global/stories/stories-library/gao-lei/index.html)

### This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.

[About us](/content/global/about-us/this-is-lundbeck/index.html)

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

[Our science](/content/global/our-science/index.html)

### Latest releases

- 03 September, 2026 Press Release  
  [Lundbeck to highlight mechanistic insights on bexicaserin’s dual mode of action at the European Epilepsy Congress](https://news.cision.com/h--lundbeck-a-s/r/lundbeck-to-highlight-mechanistic-insights-on-bexicaserin-s-dual-mode-of-action-at-the-european-epil,c4391211)
- 24 August, 2026 Press Release  
  [European Commission grants orphan designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin](https://news.cision.com/h--lundbeck-a-s/r/european-commission-grants-orphan-designation-for-lundbeck-s-investigational-anti-acth-monoclonal-an,c4386396)
- 19 August, 2026 Company Announcements  
  [Lundbeckfond Invest A/S launches voluntary exchange offer for A-shares in H. Lundbeck A/S](https://news.cision.com/h--lundbeck-a-s/r/lundbeckfond-invest-a-s-launches-voluntary-exchange-offer-for-a-shares-in-h--lundbeck-a-s,c4385004)

[See all news](/content/global/press/news-archive/index.html)

Come join us in making a difference to patients worldwide.

[Job opportunities](/content/global/careers/your-job/job-opportunities/index.html)

Explore the latest financial developments at Lundbeck.

[Investors](/content/global/investors/index.html)

### A better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person and community behind the disease.

[Our focus](/content/global/patients/index.html)

### Our sustainability strategy

Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible. We remain committed to UN Global Compact Principles, and contribute to seven of the 17 UN Sustainable Development Goals.

[Read more](/content/global/sustainability/index.html)

### Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

[Read more](/content/global/partnering/index.html)

**Mara Formentini on working at Lundbeck**

# Bringing your whole self to work and its rewards

[Read more](/content/global/stories/stories-library/mara-formentini/index.html)

[See all stories](/content/global/stories/stories-library/index.html)

Lundbeck at a glance